00000nam 2200000zi 4500 9.899807 CaOODSP 20241217173554 m o d f cr ||||||||||| 210514t20212021onc o f00| 0 eng d 9780660388816 CaOODSP eng rda CaOODSP n-cn--- H164-320/2021E-PDF Guidance document : patented medicines (notice of compliance) regulations. [Ottawa] : Health Canada = Santé Canada, 2021. ©2021 1 online resource (36 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Ligne directrice : règlement sur les médicaments brevetés (avis de conformité). Issued also in HTML format. "Effective date: 2021/05/11." "This guidance document provides information regarding the administration of the PM (NOC) Regulations by the Office of Patented Medicines and Liaison (OPML) within the Office of Submissions and Intellectual Property (OSIP), Resource Management and Operations Directorate (RMOD), Health Canada. It is applicable to drugs that receive a notice of compliance (NOC), including pharmaceutical, biological, radiopharmaceutical and veterinary drugs"--page 7. Patent medicines Canada. Pharmaceutical policy Canada. Canada. Health Canada, issuing body. Lignes directrice : (CaOODSP)9.899808 Guidance document : (CaOODSP)9.946275 Guidance document (CaOODSP)9.854770 PDF 393 KB https://publications.gc.ca/collections/collection_2021/sc-hc/H164-320-2021-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/patented-medicines/notice-compliance-regulations.html 210095